A fatal side-effect of cancer immunotherapy is pinned to a specific inflammatory circuit
Immune checkpoint inhibitors (ICIs) are powerful cancer drugs that unleash the body’s T cells against tumours, but they can trigger severe autoimmune reactions, including a frequently fatal inflammation of the heart muscle called myocarditis. Using a mouse model, researchers have now identified the precise mechanism behind this cardiotoxicity. They found that the combination of two common ICIs uniquely caused lethal heart inflammation driven by autoreactive CD8 T cells. Crucially, the damage was not caused by direct T-cell killing but by a specific inflammatory signalling pathway: the CD8 T cells released the cytokine TNF, which acted through the TNF receptor 2 (TNFR2) on other cells to recruit immune cells and disrupt heart rhythm.
Why it might matter to you:
This work provides a clear molecular target—the TNF-TNFR2 axis—for potentially separating the life-saving anti-tumor effects of immunotherapy from its dangerous cardiac side-effects. For a researcher focused on immune modulation, whether for vaccines or transplantation, this demonstrates a critical principle: severe immune-related pathology can be driven by specific inflammatory circuits rather than broad cytotoxicity. Understanding such discrete pathways offers a roadmap for designing safer adjuvants or immunotherapies where controlling collateral tissue damage is paramount.
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.